Biotech Firm Atai Life Sciences Plans to Buy $5 Million in Bitcoin
Atai Life Sciences, a NASDAQ-listed biopharmaceutical company, has announced plans to purchase $5 million worth of Bitcoin. The company, which develops mental health treatments using psychedelics such as DMT